Skip to main content

Clinical implications of interleukin-18 levels in pediatric patients with Mycoplasma pneumoniae pneumonia

Abstract

The immunological pathogenesis of Mycoplasma pneumoniae pneumonia is known to involve several cytokines. The serum levels of interleukin-18 (IL-18) were examined using enzyme-linked immunosorbent assay in 23 pediatric patients (median age 6 years; range 4–13 years; 14 girls and 9 boys) with M. pneumoniae pneumonia admitted to our hospital. Serum levels of IL-18 ranged from 22 to 1808 pg/ml with a mean of 543 pg/ml. We started steroid therapy in two cases with IL-18 values greater than 1000 pg/ml without being aware of IL-18 levels. Examination of associations between IL-18 levels determined by enzyme-linked immunosorbent assay and a routine laboratory test showed that levels of lactate dehydrogenase (LDH) and IL-18 were significantly correlated. To determine the appropriateness of steroid administration in M. pneumoniae pneumonia patients, serum LDH should be examined. Patients with elevated levels of LDH are likely to have significantly elevated IL-18 values (≥1000 pg/ml) and thus can be candidates for steroid therapy.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

References

  1. McIntosh K. Community-acquired pneumonia in children. N Engl J Med. 2002;346:429–37.

    PubMed  Article  Google Scholar 

  2. Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev. 2004;17(4):697–728.

    PubMed  Article  CAS  Google Scholar 

  3. Hoek KL, Cassell GH, Duffy LB, Atkinson TP. Mycoplasma pneumoniae-induced activation and cytokine production in rodent mast cells. J Allergy Clin Immunol. 2002;109:470–6.

    PubMed  Article  CAS  Google Scholar 

  4. Hsieh CC, Tang RB, Tsai CH, Chen W. Serum interleukin-6 and tumor necrosis factor-alpha concentrations in children with Mycoplasma pneumonia. J Microbiol Immunol Infect. 2001;34:109–12.

    PubMed  CAS  Google Scholar 

  5. Lee KY, Lee HS, Hong JH, Lee MH, Lee JS, Burgner D, et al. Role of prednisolone treatment in severe Mycoplasma pneumoniae pneumonia in children. Pediatr Pulmonol. 2006;41(3):263–8.

    PubMed  Article  Google Scholar 

  6. Lieberman D, Livnat S, Schlaeffer F, Porath A, Horowitz S, Levy R. IL-1beta and IL-6 in community-acquired pneumonia: bacteremic pneumococcal pneumonia versus Mycoplasma pneumoniae pneumonia. Infection. 1997;25:90–4.

    PubMed  Article  CAS  Google Scholar 

  7. Narita M, Tanaka H, Abe S, Yamada S, Kubota M, Togashi T. Close association between pulmonary disease manifestation in Mycoplasma pneumoniae infection and enhanced local production of interleukin-18 in the lung, independent of gamma interferon. Clin Diagn Lab Immunol. 2000;7(6):909–14.

    PubMed  CAS  Google Scholar 

  8. Narita M, Tanaka H, Yamada S, Abe S, Ariga T, Sakiyama Y. Significant role of interleukin-8 in pathogenesis of pulmonary disease due to Mycoplasma pneumoniae infection. Clin Diagn Lab Immunol. 2001;8:1028–30.

    PubMed  CAS  Google Scholar 

  9. Tanaka H, Narita M, Teramoto S, Saikai T, Oashi K, Igarashi T, et al. Role of interleukin-18 and T-helper type 1 cytokines in the development of Mycoplasma pneumoniae pneumonia in adults. Chest. 2002;121(5):1493–7.

    PubMed  Article  CAS  Google Scholar 

  10. Yang J, Hooper WC, Phillips DJ, Talkington DF. Interleukin-1β responses to Mycoplasma pneumoniae infection are cell type specific. Microb Pathog. 2003;34:17–25.

    PubMed  Article  CAS  Google Scholar 

  11. Iwata A, Izumikawa K, Sekita T, Ishimoto H, Sakamoto N, Nakayama S, et al. A case of mycoplasmal pneumonia with bronchiolitis treated with steroids. Kansenshogaku Zasshi. 2007;81(5):586–91.

    PubMed  Google Scholar 

  12. Tamura A, Matsubara K, Tanaka T, Nigami H, Yura K, Fukaya T. Methylprednisolone pulse therapy for refractory Mycoplasma pneumoniae pneumonia in children. J Infect. 2008;57(3):223–8.

    PubMed  Article  Google Scholar 

  13. Tanaka H, Okada H, Yamagishi M, Honma S, Sugawara H, Abe S, et al. Therapeutic effectiveness of prednisolone in Mycoplasma pulmonis-infected pneumonia in mice. Nihon Kyobu Shikkan Gakkai Zasshi. 1994;32(1):42–7.

    PubMed  CAS  Google Scholar 

  14. Rollins S, Colby T, Clayton F. Open lung biopsy in Mycoplasma pneumoniae pneumonia. Arch Pathol Lab Med. 1986;110:34–41.

    PubMed  CAS  Google Scholar 

  15. Llibre JM, Urban A, Garcia E, Carrasco MA, Murcia C. Bronchiolitis obliterans organizing pneumonia associated with acute Mycoplasma pneumoniae infection. Clin Infect Dis. 1997;25:1340–2.

    PubMed  Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tomohiro Oishi.

About this article

Cite this article

Oishi, T., Narita, M., Matsui, K. et al. Clinical implications of interleukin-18 levels in pediatric patients with Mycoplasma pneumoniae pneumonia. J Infect Chemother 17, 803–806 (2011). https://doi.org/10.1007/s10156-011-0265-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10156-011-0265-7

Keywords

  • Interleukin-18 (IL-18)
  • Lactate dehydrogenase (LDH)
  • Mycoplasma pneumoniae
  • Child
  • Pneumonia